Merck agreed to acquire Silence Therapeutics, according to source material published on October 19, 2026. The reported purchase consideration is $1,300,000,000. This summary is limited to the approved transaction facts in the cited source evidence.
Merck agreed to acquire Silence Therapeutics
Merck agreed to acquire Silence Therapeutics
AcquisitionUSD1,300,000,000Hospitals and Health CareGB
Get the full Silence Therapeutics company profile
Access contacts, investors, buying signals & more
Acquired
Silence Therapeutics
United KingdomHospitals and Health Care
Deal value
USD1,300,000,000
October 19, 2026
Acquirer
Merck
Pharmaceutical Manufacturing
Unlock GTM signals
Discover Silence Therapeutics's tech stack and active buying intent.
Unlock key decision-makers
Get direct access to the decision-makers at Silence Therapeutics.